RVMD
Revolution Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$210.02
−0.40%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-67.8%
Return on equity
-40.9%
Return on assets
-50.1%
Return on invested capital
0.00x
Asset turnover
-$1.6B
Cash from operations
$18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026